Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -90.61% is 111% below its 5-year average of -43.01%, around the middle of its 5-year range (-156.91%–-17.81%).
8.85% below its 12-month average of -83.24%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -57.51%.
NET PROFIT MARGIN
-90.61%
NET PROFIT MARGIN AVG TTM
-83.24%
NET PROFIT MARGIN AVG 3Y
-33.88%
NET PROFIT MARGIN AVG 5Y
-43.01%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.85%
CURRENT VS 3Y AVG
-167.44%
CURRENT VS 5Y AVG
-110.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.02%
median of 823 covered companies
CURRENT VS SECTOR MEDIAN
-452950.00%
vs the sector median at left
Health Catalyst, Inc.
Market Cap
$132.64M
Net Profit Margin
-90.61%
TTM Avg
-83.24%
3Y Avg
-33.88%
5Y Avg
-43.01%
Market Cap
$133.33M
Net Profit Margin
-7.79%
TTM Avg
-6.13%
3Y Avg
-5.81%
5Y Avg
-0.54%
Market Cap
$133.72M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$134.10M
Net Profit Margin
27.54%
TTM Avg
-18.99%
3Y Avg
-63.93%
5Y Avg
-73.34%
Market Cap
$130.75M
Net Profit Margin
-803.83%
TTM Avg
-526.75%
3Y Avg
-263.38%
5Y Avg
-175.58%
Market Cap
$135.65M
Net Profit Margin
-396.52%
TTM Avg
-411.88%
3Y Avg
-411.88%
5Y Avg
-411.88%
Market Cap
$136.91M
Net Profit Margin
-4.03%
TTM Avg
-12.22%
3Y Avg
-25.92%
5Y Avg
-21.35%
Market Cap
$138.31M
Net Profit Margin
-153.61%
TTM Avg
-101.12%
3Y Avg
-50.56%
5Y Avg
-33.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Health Catalyst, Inc. (HCAT) | $132.64M | -90.61% | -83.24% | -33.88% | -43.01% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $133.33M | -7.79% | -6.13% | -5.81% | -0.54% |
| LifeMD, Inc. (LFMD)vs › | $133.72M | -10.40% | -6.28% | -16.07% | -47.85% |
| Organigram Global Inc. (OGI)vs › | $134.10M | 27.54% | -18.99% | -63.93% | -73.34% |
| Pyxis Oncology, Inc. (PYXS)vs › | $130.75M | -803.83% | -526.75% | -263.38% | -175.58% |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.65M | -396.52% | -411.88% | -411.88% | -411.88% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.91M | -4.03% | -12.22% | -25.92% | -21.35% |
| Alpha Cognition Inc (ACOG)vs › | $138.31M | -153.61% | -101.12% | -50.56% | -33.71% |
| Entera Bio Ltd. (ENTX)vs › | $126.51M | -27235.71% | -16253.49% | -10565.36% | -7911.44% |
Operating Margin
-11.6%
Net Profit Margin
-90.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -57.51% |
| 2026-03-31 | -156.91% |
| 2025-12-31 | -121.89% |
| 2025-09-30 | -29.12% |
| 2025-06-30 | -50.76% |
| 2025-03-31 | -29.90% |
| 2024-12-31 | -25.97% |
| 2024-09-30 | -19.29% |
| 2024-06-30 | -17.81% |
| 2024-03-31 | -27.55% |
| 2023-12-31 | -40.37% |
| 2023-09-30 | -29.86% |
| 2023-06-30 | -44.55% |
| 2023-03-31 | -44.93% |
| 2022-12-31 | -51.74% |
| 2022-09-30 | -66.91% |
| 2022-06-30 | -47.33% |
| 2022-03-31 | -32.98% |
| 2021-12-31 | -75.70% |
| 2021-09-30 | -64.81% |
| 2021-06-30 | -60.10% |
| 2021-03-31 | -50.80% |
| 2020-12-31 | -80.74% |
| 2020-09-30 | -57.91% |
| 2020-06-30 | -62.84% |
| 2020-03-31 | -38.77% |
| 2019-12-31 | -32.79% |
| 2019-09-30 | -54.32% |
| 2019-06-30 | -29.06% |
| 2019-03-31 | -38.96% |
| 2018-12-31 | -37.62% |
| 2018-09-30 | -51.34% |
| 2018-06-30 | -84.05% |
| 2018-03-31 | -59.18% |
